432 related articles for article (PubMed ID: 34739462)
1. An assessment of case-fatality and infection-fatality rates of first and second COVID-19 waves in Italy.
Filippini T; Zagnoli F; Bosi M; Giannone ME; Marchesi C; Vinceti M
Acta Biomed; 2021 Oct; 92(S6):e2021420. PubMed ID: 34739462
[TBL] [Abstract][Full Text] [Related]
2. First wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate.
Vial PA; González C; Apablaza M; Vial C; Lavín ME; Araos R; Rubilar P; Icaza G; Florea A; Pérez C; Concha P; Bastías D; Errázuriz MP; Pérez R; Guzmán F; Olea A; Guzmán E; Correa J; Munita JM; Aguilera X
Epidemics; 2022 Sep; 40():100606. PubMed ID: 35872438
[TBL] [Abstract][Full Text] [Related]
3. Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.
Pachetti M; Marini B; Giudici F; Benedetti F; Angeletti S; Ciccozzi M; Masciovecchio C; Ippodrino R; Zella D
J Transl Med; 2020 Sep; 18(1):338. PubMed ID: 32878627
[TBL] [Abstract][Full Text] [Related]
4. Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.
Tunheim G; Rø GØI; Tran T; Kran AB; Andersen JT; Vaage EB; Kolderup A; Vaage JT; Lund-Johansen F; Hungnes O
Influenza Other Respir Viruses; 2022 Mar; 16(2):204-212. PubMed ID: 34751488
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 infection incidence during the first and second COVID-19 waves in Italy.
Vinceti M; Filippini T; Rothman KJ; Di Federico S; Orsini N
Environ Res; 2021 Jun; 197():111097. PubMed ID: 33811866
[TBL] [Abstract][Full Text] [Related]
6. Increased SARS-CoV-2 seroprevalence in healthy blood donors after the second pandemic wave in South-Eastern Italy: evidence for asymptomatic young donors as potential virus spreaders.
Antonucci F; Fiore JR; De Feo L; Granato T; Di Stefano M; Faleo G; Farhan AM; Margaglione M; Centra M; Santantonio TA
Infect Dis (Lond); 2022 Apr; 54(4):241-246. PubMed ID: 34781812
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study.
Stefanelli P; Bella A; Fedele G; Pancheri S; Leone P; Vacca P; Neri A; Carannante A; Fazio C; Benedetti E; Fiore S; Fabiani C; Simmaco M; Santino I; Zuccali MG; Bizzarri G; Magnoni R; Benetollo PP; Merler S; Brusaferro S; Rezza G; Ferro A
Clin Microbiol Infect; 2021 Apr; 27(4):633.e1-633.e7. PubMed ID: 33253941
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 infection fatality rate after the first epidemic wave in Mexico.
Torres-Ibarra L; Basto-Abreu A; Carnalla M; Torres-Alvarez R; Reyes-Sanchez F; Hernández-Ávila JE; Palacio-Mejia LS; Alpuche-Aranda C; Shamah-Levy T; Rivera JA; Barrientos-Gutierrez T
Int J Epidemiol; 2022 May; 51(2):429-439. PubMed ID: 35157072
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020-March 2021.
Kleynhans J; Tempia S; Wolter N; von Gottberg A; Bhiman JN; Buys A; Moyes J; McMorrow ML; Kahn K; Gómez-Olivé FX; Tollman S; Martinson NA; Wafawanaka F; Lebina L; du Toit J; Jassat W; Neti M; Brauer M; Cohen C;
Emerg Infect Dis; 2021 Dec; 27(12):3020-3029. PubMed ID: 34477548
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
[TBL] [Abstract][Full Text] [Related]
11. First Wave of COVID-19 Pandemic in Italy: Data and Evidence.
Bezzini D; Schiavetti I; Manacorda T; Franzone G; Battaglia MA
Adv Exp Med Biol; 2021; 1353():91-113. PubMed ID: 35137370
[TBL] [Abstract][Full Text] [Related]
12. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
13. Determining the Case Fatality Rate of COVID-19 in Italy: Novel Epidemiological Study.
Yan M; Kang W; Guo Z; Wang Q; Wang PP; Zhu Y; Yang Y; Wang W
JMIR Public Health Surveill; 2022 Feb; 8(2):e32638. PubMed ID: 34963659
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and risk factors of isolated and quarantined children and adolescents during the first wave of SARS-CoV-2 pandemic: A cross-sectional study in Modena, Northern Italy.
Paduano S; Facchini MC; Greco A; Borsari L; Mingrone VM; Tancredi S; Fioretti E; Creola G; Iacuzio L; Casaletti G; Vinceti M; Bargellini A; Filippini T
Acta Biomed; 2021 Oct; 92(S6):e2021449. PubMed ID: 34739471
[TBL] [Abstract][Full Text] [Related]
15. The association between first and second wave COVID-19 mortality in Italy.
Vinceti M; Filippini T; Rothman KJ; Di Federico S; Orsini N
BMC Public Health; 2021 Nov; 21(1):2069. PubMed ID: 34763690
[TBL] [Abstract][Full Text] [Related]
16. As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation.
Rubino S; Kelvin N; Bermejo-Martin JF; Kelvin D
J Infect Dev Ctries; 2020 Mar; 14(3):265-267. PubMed ID: 32235086
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19.
Esposito S; Neglia C; Affanni P; Colucci ME; Argentiero A; Veronesi L; Messina G; Deolmi M; Principi N;
Front Public Health; 2021; 9():628098. PubMed ID: 34249830
[No Abstract] [Full Text] [Related]
18. Estimating the wave 1 and wave 2 infection fatality rates from SARS-CoV-2 in India.
Purkayastha S; Kundu R; Bhaduri R; Barker D; Kleinsasser M; Ray D; Mukherjee B
BMC Res Notes; 2021 Jul; 14(1):262. PubMed ID: 34238344
[TBL] [Abstract][Full Text] [Related]
19. Excess Mortality in Italy During the COVID-19 Pandemic: Assessing the Differences Between the First and the Second Wave, Year 2020.
Dorrucci M; Minelli G; Boros S; Manno V; Prati S; Battaglini M; Corsetti G; Andrianou X; Riccardo F; Fabiani M; Vescio MF; Spuri M; Urdiales AM; Martina DM; Onder G; Pezzotti P; Bella A
Front Public Health; 2021; 9():669209. PubMed ID: 34336767
[TBL] [Abstract][Full Text] [Related]
20. Two years of SARS-CoV-2 pandemic and COVID-19 in Lombardy, Italy.
Mannucci PM; Galbussera AA; D'Avanzo B; Tettamanti M; Remuzzi G; Fortino I; Leoni O; Harari S; Nobili A
Intern Emerg Med; 2023 Aug; 18(5):1445-1451. PubMed ID: 37314640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
